Evidence map›Paper›PMID 42775105›Full record

ReviewFrontiers in immunology2026

The potential of platelet-rich plasma and PRP-derived biologics for neurological disorders: mechanisms and translational research.

Guina Tan, Xiaoxin Wang, Jing Chen, Ru Feng, Hongyu Chu, Degang Yang, Jun Li, Mingliang Yang, Ying Huang, Jianjun Li and 1 more

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Guina TanSchool of Rehabilitation, Gannan Medical University, Ganzhou, Jiangxi, China.
Xiaoxin WangDepartment of Spinal and Neural Functional Reconstruction, China Rehabilitation Research Center, Beijing, China.
Jing ChenDepartment of Spinal and Neural Functional Reconstruction, China Rehabilitation Research Center, Beijing, China.
Ru FengDepartment of Spinal and Neural Functional Reconstruction, China Rehabilitation Research Center, Beijing, China.
Hongyu ChuDepartment of Rehabilitation Medicine, Peking University Hospital, Beijing, China.
Degang YangDepartment of Spinal and Neural Functional Reconstruction, China Rehabilitation Research Center, Beijing, China.
Jun LiDepartment of Spinal and Neural Functional Reconstruction, China Rehabilitation Research Center, Beijing, China.
Mingliang YangDepartment of Spinal and Neural Functional Reconstruction, China Rehabilitation Research Center, Beijing, China.
Ying HuangSchool of Rehabilitation, Gannan Medical University, Ganzhou, Jiangxi, China.
Jianjun LiDepartment of Spinal and Neural Functional Reconstruction, China Rehabilitation Research Center, Beijing, China.
Feng GaoDepartment of Spinal and Neural Functional Reconstruction, China Rehabilitation Research Center, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Platelet-rich plasma (PRP), an autologous blood derivative rich in multiple growth factors and cytokines, has shown broad application prospects in the field of tissue repair and regeneration. In recent years, the therapeutic potential of PRP in neurological disorders has gained increasing attention. This article systematically reviews the classification systems, preparation methods, and the molecular mechanisms and application progress of PRP in neural repair. In preclinical studies, PRP has been shown to release insulin-like growth factor-1 (IGF-1), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor-β (TGF-β), which may synergistically activate PI3K/Akt and MAPK/ERK signaling pathways, suggesting potential tissue repair, axonal regenerative, angiogenic, and immunomodulatory effects. The three-dimensional fibrin scaffold formed upon platelet activation not only provides physical support for cell migration and axonal growth but also enables the sustained local release of growth factors. In central nervous system disorders, intrathecal PRP has shown potential in animal models to alleviate neuroinflammation after spinal cord injury(SCI), and intranasal administration can improve cognitive function and neurogenesis in Alzheimer's disease(AD) models. In peripheral nervous system disorders, local injection or PRP filling within nerve conduits significantly promotes regeneration and functional recovery after injuries to the sciatic nerve, facial nerve, and others. Furthermore, the therapeutic efficacy of PRP is influenced by factors such as preparation method, cellular composition (leukocyte content), administration route, and activation method. Although preclinical evidence is substantial, the clinical application of PRP in neurological disorders still faces challenges including a lack of standardization, unclear mechanisms, and the need to verify long-term safety. This review aims to provide a theoretical basis and practical reference for further research and clinical translation of PRP in the field of neural repair.

Indexed as

Biological ProductsNervous System DiseasesPlatelet-Rich PlasmaAnimalsHumansNerve RegenerationTranslational Research, BiomedicalBiological Productsadministration routesaxonal regenerationneural repairneuroinflammationplatelet-rich plasma (PRP)

Identifiers

PMID42775105
PMCPMC13595135

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.